Skip to main content

Table 1 Patient demographic data

From: Reduced cGMP levels in CSF of AD patients correlate with severity of dementia and current depression

 

Control (n = 65)

AD (n = 68)

p value

Age (years)

59 (54–71)

70 (66–75)

<0.01

Sex, male/female (n)

37/28

25/43

0.021

ApoE ε4 carriers (%)

23.1

52.9

 

Tau (pg/ml)

229.5 (172.25–292)

907 (641.5–1100.5)

<0.01

Aβ42 (pg/ml)

1012.5 (850.75–1177.25)

493 (390.5–556)

<0.01

MMSE score

29 (27–30)

20 (16–23)

<0.01

  1. Data presented as median (interquartile range) unless otherwise stated. p values calculated using the Mann–Whitney test, AD vs control
  2. AD Alzheimer’s disease, MMSE Mini-Mental State Examination